Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anal neoplasms.

Harvey G Moore1, José G Guillem

  • 1Colorectal Surgery Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA. guillemj@mskcc.org

The Surgical Clinics of North America
|January 9, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk of Metachronous Colorectal Cancer After Segmental or Extended Resection in Patients with Lynch Syndrome.

Journal of the American College of Surgeons·2026
Same author

A history of the collaborative group of the Americas on inherited gastrointestinal cancer (CGA-IGC): 1995-2025.

Familial cancer·2026
Same author

Impact of COVID-19 on Universal Tumor Screening, Referral Rates and Attendance at Cancer Genetic Counseling at a Safety-Net University Hospital.

Current oncology (Toronto, Ont.)·2025
Same author

Disparities in Outcomes following Resection of Locally Advanced Rectal Cancer.

Current oncology (Toronto, Ont.)·2024
Same author

Watch and Wait for Near-Complete Responders-A Word of Caution.

JAMA oncology·2024
Same author

Factors Associated With Performing IPAA After Total Colectomy for Ulcerative Colitis.

Diseases of the colon and rectum·2024
Same journal

Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
Same journal

Beyond the Scalpel's Reach.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Society.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Hospitals.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions for Providers.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Patients Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
See all related articles

Early detection of anal neoplasms is crucial, as delays often stem from misdiagnosis. Chemoradiation offers effective treatment for squamous cell carcinoma (SCC) of the anal canal, often preserving sphincter function.

Area of Science:

  • Gastroenterology
  • Oncology
  • Surgical Oncology

Background:

  • Anal neoplasms are frequently diagnosed late due to initial misidentification as benign conditions.
  • A high index of suspicion is essential for clinicians evaluating anal canal and margin lesions.

Purpose of the Study:

  • To review current treatment strategies for anal neoplasms.
  • To highlight the efficacy of chemoradiation for squamous cell carcinoma (SCC) of the anal canal.
  • To discuss the role of surgery in specific scenarios and the prognosis of rarer anal tumors.

Main Methods:

  • Literature review of studies on anal neoplasms.
  • Analysis of treatment outcomes for SCC of the anal canal.
  • Evaluation of surgical salvage and management of treatment failures.

Related Experiment Videos

Main Results:

  • Primary chemoradiation for anal canal SCC shows comparable or superior local control and survival to radical surgery, with over two-thirds of patients preserving sphincter function.
  • Abdominoperineal resection remains vital for salvage in treatment failures and for patients unable to tolerate chemoradiation or with pre-existing incontinence.
  • Anorectal melanoma, small cell, and undifferentiated tumors have a poor prognosis.

Conclusions:

  • Chemoradiation is a primary treatment for anal canal SCC, balancing efficacy with sphincter preservation.
  • Surgical intervention is reserved for specific cases, including treatment failures and patient-specific contraindications.
  • Rarer anal tumors like melanoma and small cell carcinoma present significant prognostic challenges.